Page last updated: 2024-11-11

awd 12-281

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

AWD 12-281: phosphodiesterase 4 inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918428
CHEMBL ID3218685
SCHEMBL ID155120
MeSH IDM0444396

Synonyms (30)

Synonym
awd-12-281
gw-842470
gsk-842470
awd 12-281
n-(3,5-dichloropyrid-4-yl)-(1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl)glyoxylic acid amide
n-(3,5-dichloropyridin-4-yl)-2-[1-[(4-fluorophenyl)methyl]-5-hydroxyindol-3-yl]-2-oxoacetamide
gsk 842470
257892-33-4
gw 842470
550671j24d ,
unii-550671j24d
247584-20-9
1h-indole-3-acetamide, n-(3,5-dichloro-4-pyridinyl)-1-((4-fluorophenyl)methyl)-5-hydroxy-.alpha.-oxo-
CHEMBL3218685
AKOS022178805
n-(3,5-dichloropyridin-4-yl)-2-[1-(4-fluorobenzyl)-5-hydroxyindol-3-yl]-2 -oxoacetamide
n-(3,5-dichloropyridin-4-yl)-2-[1-(4-fluorobenzyl)-5-hydroxyindol-3-yl]-2-oxoacetamide
n-(3,5-dichloropyridin-4-yl)-2-[1-(4-fluorobenzyl)-5-hydroxyindol-3yl]-2-oxoacetamide
DPHDSIQHVGSITN-UHFFFAOYSA-N
n-(3,5-dichloropyridin-4-yl)-2-[1-(4-fluorobenzyl)-5-hydroxyindol-3-yl]2-oxoacetamide
SCHEMBL155120
DTXSID60180453
awd12-281
awd 12-281; awd12-281; unii-550671j24d; gsk 842470; gsk 842470; gsk-842470
BCP12446
awd 12-281; gsk 842470
Q27261253
n-(3,5-dichloro-pyridin-4-yl)-2-[1-(4-fluoro-benzyl)-5-hydroxy-1h-indol-3-yl]-2-oxo-acetamide
A857629
n-(3,5-dichloropyridin-4-yl)-2-[1-(4-fluorobenzyl)-5-hydroxy-1h-indol-3-yl]-2-oxo-acetamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.46 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (28.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]